Treatment of papuloerythroderma of Ofuji with Re-PUVA: a case report and review of the therapy

Mutluer S., Yerebakan O., Alpsoy E., Ciftcioglu M. A., Yilmaz E.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, vol.18, no.4, pp.480-483, 2004 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 18 Issue: 4
  • Publication Date: 2004
  • Doi Number: 10.1111/j.1468-3083.2004.00930.x
  • Journal Name: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.480-483
  • Keywords: papuloerythroderma, 'deck-chair' sign, acitretin, PLTVA, Re-PUVA, review, HIV-INFECTED PATIENT, CYCLOSPORINE, CARCINOMA, LYMPHOMA
  • Akdeniz University Affiliated: Yes

Abstract

Papuloerythroderma of Ofuji (PEO) is a disease of elderly men, characterized by intensely pruritic and widespread, red, flat-topped papules with sparing of the body folds and creases (the so-called 'deck-chair' sign). The etiopathogenesis of the disease remains unknown. Psoralen plus UVA (PUVA), topical and systemic corticosteroids, etretinate, cyclosporin and interferon are the main approaches in the treatment of this rare disease. A case of PEO in a 60-year-old man who responded to retinoid plus PUVA (Re-PUVA) treatment is reported here and a review of the therapy with other relevant cases is presented.